John W. Villiger
Director/Board Member at Auckland UniServices Ltd.
John W. Villiger active positions
| Companies | Position | Start | End |
|---|---|---|---|
Auckland UniServices Ltd.
 Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Director/Board Member | - | - |
Career history of John W. Villiger
Former positions of John W. Villiger
| Companies | Position | Start | End |
|---|---|---|---|
| SYNTARA LIMITED | Director/Board Member | 01/11/2006 | 19/09/2013 |
| Independent Dir/Board Member | 17/06/2011 | 19/09/2013 | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
| THE MEDICINES COMPANY | Founder | 31/07/1996 | - |
| Corporate Officer/Principal | 31/07/1996 | - | |
Proacta, Inc.
 Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Director/Board Member | 01/01/2004 | 23/02/2010 |
| Chairman | 23/02/2010 | - |
Training of John W. Villiger
| University of Otago | Doctorate Degree |
Statistics
International
| United States | 4 |
| New Zealand | 3 |
| Australia | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Proacta, Inc.
Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Auckland UniServices Ltd.
Auckland UniServices Ltd. Investment ManagersFinance Founded in 1988, Auckland UniServices Ltd is a venture capital arm of University of Auckland , New Zealand founded in 1988. The Firm headquartered in New Zealand. | Finance |
- Stock Market
- Insiders
- John W. Villiger
- Experience
